Novel method of progesterone delivery and affect thereof.
MYPI1994002436A0Inactive Publication Date: 1995-03-15COLUMBIA LABORATORIES (BERMUDA) LIMITED
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI1994002436
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 1993-09-15
- Filing Date
- 1994-09-14
- Publication Date
- 1995-03-15
- Estimated Expiration
- Not applicable · inactive patent
Abstract
THE PRESENT INVENTION TEACHES THAT RELATIVELY LOW LEVELS OF SERUM PROGESTERONE, 1 TO 6 NG / ML, MAY BE USED TO PREVENT ENDOMETRIAL CANCER. THE VAGINAL DELIVERY OF PROGESTERONE USING A CROSS-LINKED POLYCARBOXYLIC POLYMER PRODUCES THIS LOW SERUM PROGESTERONE LEVEL WHILE ALSO PROVIDING THE FULL SECRETORY TRANSFORMATION OF THE ENDOMETRIUM, INDICATING THE EFFICACY OF THE PROGESTERONE. SUCH LOW LEVELS OF SERUM PROGESTERONE WILL DECREASE THE RISK OF BREAST CANCER EXPERIENCED BY WOMEN UNDERGOING HORMONE REPLACEMENT THERAPY ("HRT") AND MINIMIZE THE POTENTIAL OF OTHER UNDESIRABLE PROGESTERONE ASSOCIATED SIDE EFFECTS.
Need to check novelty before this filing date? Find Prior Art
